Pacific Biosciences Of California PACB
NASDAQ PACB
$1.25 +0.02 (+2.03%)
As of: Aug 21, 2026 · 10:14 AM EDT

Pacific Biosciences Of California (PACB) Retained Earnings (2010 - 2026)

Pacific Biosciences Of California (PACB) posted quarterly Retained Earnings of -$147000.0 for Q1 2026, down 138.58% year-over-year from $381000.0 in Q1 2025, and up 99.99% quarter-over-quarter from -$2.7 billion in Q4 2025.

Pacific Biosciences Of California (PACB) Retained Earnings (2010 - 2026) Analysis & Trends

Pacific Biosciences Of California's Retained Earnings history runs 17 years deep, the most recent figure standing at -$147000.0 for Q1 2026.

  • In Q1 2026, Retained Earnings fell 138.58% year-over-year to -$147000.0; the TTM figure through Mar 2026 stood at -$147000.0 (down 138.58% YoY), while the FY2025 annual figure was -$2.7 billion, down 25.43% from the prior year.
  • Retained Earnings for Q1 2026 stood at -$147000.0, up from -$2.7 billion in the prior quarter.
  • The five-year high for Retained Earnings was $2.6 billion in Q2 2024, with the low at -$2.7 billion in Q4 2025.
  • The 5-year median for Retained Earnings is -$147000.0 (2026), against an average of -$99.1 million.
  • The sharpest annual moves came in 2022 and 2023: Retained Earnings surged 193272.22% in 2022, then sank 39565.97% in 2023.
  • Pacific Biosciences Of California's Retained Earnings stood at $2.1 billion in 2022, then plunged by 187.58% to -$1.8 billion in 2023, then slipped by 16.85% to -$2.1 billion in 2024, then decreased by 25.43% to -$2.7 billion in 2025, then soared by 99.99% to -$147000.0 in 2026.
  • Business Quant data shows PACB's Retained Earnings at -$147000.0 in Q1 2026, -$2.7 billion in Q4 2025, and $415000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Abbott Laboratories 200.79 Bn 195.19 Bn 7.27 Bn 49.79 Bn
2 Stryker 125.96 Bn 122.49 Bn 4.50 Bn 21.82 Bn
3 Medtronic 118.43 Bn 109.21 Bn 6.41 Bn 32.64 Bn
4 Boston Scientific 73.13 Bn 72.59 Bn 3.85 Bn 7.82 Bn
5 Edwards Lifesciences 51.63 Bn 47.38 Bn 1.35 Bn 14.86 Bn
6 Dexcom 34.60 Bn 32.65 Bn 830.00 Mn 2.88 Bn
7 GE HealthCare Technologies 33.71 Bn 31.60 Bn 2.18 Bn 6.78 Bn
8 Koninklijke Philips 26.17 Bn 22.85 Bn 4.55 Bn -
9 Steris 23.14 Bn 22.66 Bn 684.20 Mn 3.15 Bn
10 Pacific Biosciences Of California 389.87 Mn 153.00 Mn 12.64 Mn -2.75 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.75 Bn
Mar 31, 2026 -147,000.00
Dec 31, 2025 -2.70 Bn
Sep 30, 2025 415,000.00
Jun 30, 2025 -2.62 Bn
Mar 31, 2025 381,000.00
Dec 31, 2024 -2.15 Bn
Sep 30, 2024 1.55 Mn
Jun 30, 2024 2.58 Bn
Mar 31, 2024 -1.92 Bn
Dec 31, 2023 -1.84 Bn
Sep 30, 2023 -1.84 Mn
Jun 30, 2023 2.33 Bn
Mar 31, 2023 -1.62 Bn
Dec 31, 2022 2.10 Bn
Sep 30, 2022 2.08 Bn
Jun 30, 2022 2.06 Bn
Mar 31, 2022 -4.09 Mn
Dec 31, 2021 -1.09 Mn
Jun 30, 2021 1.42 Bn